Literature DB >> 9291832

The role of protein kinase C in GH secretion induced by GH-releasing factor and GH-releasing peptides in cultured ovine somatotrophs.

D Wu1, I J Clarke, C Chen.   

Abstract

The involvement of protein kinase C (PKC) in the action of GH-releasing factor (GRF) and synthetic GH-releasing peptides (GHRP-2 and GHRP-6) was investigated in ovine somatotrophs in primary culture. In partially purified sheep somatotrophs, GRF and GHRP-2 caused translocation of PKC activity from the cytosol to the cell membranes and caused GH release in a dose- and time-dependent manner. GHRP-6 did not cause PKC translocation. The PKC inhibitors, calphostin C, staurosporine and chelerythrine, partially reduced GH release in response to GRF and GHRP-2 at doses which selectively inhibit PKC activity. These inhibitors totally abolished GH release caused by phorbol 12-myristate 13-acetate (PMA). Down-regulation of PKC by the treatment of cells with phorbol 12,13-dibutyrate for 16 h caused a significant (P < 0.001) reduction in total PKC activity and totally abolished PKC translocation in response to a challenge with GRF, GHRP-2 or PMA. In addition, down-regulation abolished GH release in response to GRF, GHRP-2 or GHRP-6. Treatment of cells with H89, a selective PKA inhibitor, totally blocked GH release caused by either GRF or GHRP-2 and partially reduced PMA-induced GH release. H89 had no effect on PKC translocation caused by GRF, GHRP-2 or PMA and did not affect GH release caused by GHRP-6. These data suggest that GHRP-2 and GRF activate PKC in addition to stimulating adenylyl cyclase activity. Although the cAMP-protein kinase A (PKA) pathway is the major signalling pathway employed by GRF and GHRP-2, the activation of PKC may potentiate signalling via the cAMP-PKA pathway in ovine GH secretion. Importantly, the effect of PMA in increasing the secretion of GH from ovine somatotrophs is effected, in part, by up-regulation of the cAMP-PKA pathway. We conclude that there is cross-talk between the PKC pathway and the cAMP-PKA pathway in ovine somatotrophs during the action of GRF or GHRP.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9291832     DOI: 10.1677/joe.0.1540219

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  5 in total

1.  Effect of gsp oncogene on somatostatin receptor subtype 1 and 2 mRNA levels in GHRH-responsive GH3 cells.

Authors:  Eunhee Kim; Sookjin Sohn; Mina Lee; Cheolyoung Park; Jeechang Jung; Seungjoon Park
Journal:  Pituitary       Date:  2005       Impact factor: 4.107

2.  Human GHRH reduces voltage-gated K+ currents via a non-cAMP-dependent but PKC-mediated pathway in human GH adenoma cells.

Authors:  R Xu; S G Roh; K Loneragan; M Pullar; C Chen
Journal:  J Physiol       Date:  1999-11-01       Impact factor: 5.182

3.  Differential secretion of chicken growth hormone variants after growth hormone-releasing hormone stimulation in vitro.

Authors:  Hilda Martínez-Coria; L Javier López-Rosales; Martha Carranza; Laura Berumen; Maricela Luna; Carlos Arámburo
Journal:  Endocrine       Date:  2002-03       Impact factor: 3.925

4.  Upregulation of voltage-gated calcium channel cav1.3 in bovine somatotropes treated with ghrelin.

Authors:  V M Salinas Zarate; A Magdaleno Méndez; B Domínguez Mancera; A Rodríguez Andrade; M Barrientos Morales; P Cervantes Acosta; A Hernández Beltrán; D Romero Salas; J L V Flores Hernández; E Monjaraz Guzmán; D R Félix Grijalva
Journal:  J Signal Transduct       Date:  2013-12-18

5.  Growth hormone-releasing peptide-2 (GHRP-2) does not act via the human growth hormone-releasing factor receptor in GC cells.

Authors:  C Chen; P Farnworth; S Petersenn; I Musgrave; B J Canny; I J Clarke
Journal:  Endocrine       Date:  1998-08       Impact factor: 3.925

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.